荆门市维蒂娜美甲加盟电话多少钱辽阳市酷女孩美甲加盟电话多少钱,荣昌区茉哉美甲加盟电话多少钱,鹤壁市嗨创美365美甲加盟电话多少钱,珠海市咖啡遇见美甲加盟电话多少钱,南川区98元自助美甲加盟电话多少钱,广州市觅町美甲加盟电话多少钱,六安市iu美甲加盟电话多少钱

BEIJING, Feb. 20 (Xinhua) -- Chinese Vice Premier Wang Qishan on Sunday called for sound and fast development of the nation's tourism industry as he called it a strategic pillar of the national economy.The tourism industry has huge potential, which needs further opening up, reform and innovation. Market should play a fundamental role in allocating the resources, Wang told a meeting of tourism work.He stressed the diversified needs of customers should be met, and the market order should be standardized to protect customer's legitimate rights."Local authorities should work together to make tourism a strategic pillar industry," he said.Wang also noted tour guide forces play a very important role in the industry development.More training should be arranged in the areas of professional skills and ethics, as well as response to emergencies.The wage and social security system of the work force should also be improved, he said.

MOSCOW, Jan. 24 (Xinhua) -- Russian President Dmitry Medvedev and visiting Chinese State Councilor Dai Bingguo held talks here on Monday, discussing prospects for the development of cooperation between the two countries.Medvedev and Dai Bingguo discussed the development of Russian- Chinese bilateral cooperation and interaction on the international arena.The Russian president said the Sino-Russian strategic partnership of coordination is developing further in all aspects, as the leaders of the two nations kept close contact during last year and cooperation in the economic and trade sphere has been deepened.Russia sees China as its closest partner, a position that will never be changed, Medvedev stressed.Russia is willing to work together with China to promote all- around cooperation and coordination on international and regional issues, Medvedev said.He said the strategic security talks between Russia and China, a major goal of Dai's current visit, have served as an important channel for bilateral coordination and exchanges, and played a pivotal role in enhancing bilateral strategic mutual trust.Dai Bingguo, who arrived in Moscow Sunday for a three-day visit, said that the first ten years of the 21st century had been important for Sino-Russian relations.China attaches great importance to the strategic coordination with Russia and is willing to work with Russia to develop their strategic partnership of coordination at a higher stage, the Chinese state councilor said.

WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.

SAN FRANCISCO, April 18 (Xinhua) -- Apple Inc. has sued Samsung Electronics Co. over patent infringement in a latest suit, U.S. media reported Monday.The suit, filed last Friday in U.S. District Court in Northern California, alleged that Samsung's smartphones, such as "Glaxy S 4G" and "Nexus S," and the Galaxy line of tablet computers violated Apple's patent and trademark, according to All Things Digital, a technology and startup company news site."It's no coincidence that Samsung's latest products look a lot like the iPhone and iPad, from the shape of the hardware to the user interface and even the packaging," the report quoted an Apple representative as saying.Intellectual property suits can be often seen among mobile computing rivals, including suits between Microsoft and Motorola, a suit by Oracle against Google, and Apple's patent dispute with Nokia and HTC.Although Samsung supplies chips for a number of Apple products, Apple CEO Steve Jobs once openly mocked Samsung and other tablet makers as "copycats" during the iPad2 launch. Last month, Apple is reportedly partnering with China's Taiwan Semiconductor Manufacturing Co. to make iPad chips.

BEIJING, April 12 (Xinhuanet) -- A new research indicats taking vitamin D could ward off vision loss from age-related macular degeneration (AMD) in women younger than 75, according to media reports on Tuesday.In the research, women under 75 who consumed sufficient vitamin D cut their risk of developing early age-related AMD, a leading cause of vision loss and blindness, by 59 percent when compared to women with vitamin D-poor diets.Researchers found that vitamin D levels among patients in the study were most affected by the amount of vitamin D they consumed, through certain fish, dairy, eggs, and leafy greens, not by the amount of outdoor exposure they had. Considering many Americans are actually deficient in vitamin D, this study may offer one more reason for women to include vitamin D-rich foods in the diet, said the lead author on the study, Amy Millen of the University of Buffalo.